Clinical Trials Browser

Phase 2 × capivasertib × Gastrointestinal × Clear all

NCT02451956 2019-12-30

Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer